Skylands Capital’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-14,800
Closed -$251K 191
2016
Q3
$251K Buy
+14,800
New +$274K 0.04% 154
2016
Q2
Sell
-33,246
Closed -$637K 193
2016
Q1
$637K Buy
+33,246
New +$636K 0.1% 132

Other funds holding IRMD

Skylands Capital's IRMD Position: Q4 2016 in Review

Skylands Capital sold out of iRadimed (IRMD) in Q4 2016, closing a stake of 14,800 shares — an estimated $251K sold.

Skylands Capital first reported a position in IRMD in Q1 2016 and held it in 2 quarters. The position peaked at $637K in Q1 2016. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

  • Skylands Capital reported no remaining iRadimed position as of Q4 2016 after selling out during the quarter.
  • Skylands Capital sold 14,800 iRadimed shares in Q4 2016, an estimated $251K.
  • Skylands Capital first reported a position in iRadimed in Q1 2016 and held it in 2 quarters.
  • Skylands Capital's iRadimed position peaked at $637K in Q1 2016.
  • 58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on Skylands Capital's 13F filing for Q4 2016, filed 19 Jan 2017.